← Leaderboards
Christopher D Johnston
Ada Forsyth Institute, Inc.
$6,639,228
Attributed
$7,894,195
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,894,195 · 5
By mechanism
R01$6,969,231 · 3
R21$924,964 · 2
Top collaborators
- Angela H Ting2 shared
- Susan Bullman1 shared
- Yiyin Erin Chen1 shared
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticMicrobeBacteriaMemberMicrobialCollectionEpigenetic ProcessOralGenetic EngineeringDesignComplexPreventCellsModificationMetabolismMethylationDna MethylationInterestPlasmidsOral MicrobiomeMicrobiologyEnvironmentInnovationClustered Regularly Interspaced Short Palindromic Repeats
Grant awards (13)
Deciphering the Critical Determinants of Enteric and Tumor Niche Colonization by Microbes in Colorectal Cancer$697,763
R01 · FY2025 · CA · contact PI
Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer$676,366
R01 · FY2025 · CA · contact PI
Engineering diverse commensal skin bacteria for targeted immunotherapy$443,564
R21 · FY2025 · CA
Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer$692,241
R01 · FY2024 · CA · contact PI
Advanced genetic systems for Fusobacterium nucleatum in oral and extra-oral pathologies$361,755
R21 · FY2023 · DE · contact PI
Advanced genetic systems for Fusobacterium nucleatum in oral and extra-oral pathologies$119,645
R21 · FY2023 · DE · contact PI
THE SYNGENICDNA AND UPOET PLATFORM: OVERCOMING INNATE BARRIERS TO GENETIC ENGINEE$641,645
R01 · FY2021 · DE · contact PI
The SyngenicDNA and ÃÂÃÂÃÂÃÂÃÂÃÂÃÂüPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.$121,749
R01 · FY2021 · DE · contact PI
The SyngenicDNA and ÃÂÃÂÃÂÃÂÃÂÃÂÃÂüPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.$770,399
R01 · FY2020 · DE · contact PI
The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.$748,718
R01 · FY2019 · DE · contact PI
The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.$581,864
R01 · FY2018 · DE · contact PI
The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.$473,351
R01 · FY2018 · DE · contact PI
The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.$1,565,135
R01 · FY2017 · DE · contact PI